Yes, but with each trial stage a particular vaccine candidate passes, its likelihood of failing the further stages goes down. Most candidates that are going to fail, do so in the lab or in Phase 1 trials. A vaccine candidate that passes Phase 1 and Phase 2 has a pretty good outlook.